Business profile not generated.
Run python -m application.cli.business_profile run --market US --one NVNO, then regenerate the site.
A filing-first public record from Lucide House.
Issue 000 | U.S. Pilot | US
enVVeno Medical Corp
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Business profile not generated.
Run python -m application.cli.business_profile run --market US --one NVNO, then regenerate the site.
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
2019-12-31
10-K
USD
|
2018-12-31
10-K
USD
|
|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 31,243 | 186,552 |
| Operating Income | -20,899,000 | -23,826,000 | -25,238,000 | -24,932,000 | -16,892,503 | -9,135,126 | -7,675,312 | -7,854,785 |
| Net Income | -19,472,000 | -21,819,000 | -23,516,000 | -24,669,000 | -16,527,822 | -9,135,486 | -7,625,397 | -13,042,709 |
| Cash From Operations | -15,568,000 | -16,838,000 | -18,858,000 | -15,619,000 | -11,845,846 | -7,677,210 | -5,896,400 | -6,355,838 |
| Capex | -5,000 | -37,000 | -33,000 | -115,000 | -367,890 | -180,291 | -363,891 | -12,422 |
| Free Cash Flow | -15,573,000 | -16,875,000 | -18,891,000 | -15,734,000 | -12,213,736 | -7,857,501 | -6,260,291 | -6,368,260 |
| Cash And Equivalents | 3,065,000 | 1,754,000 | 3,620,000 | 4,555,000 | 54,727,740 | 9,334,584 | 1,307,231 | 2,740,645 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 32,022 |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 28,826,000 | 43,734,000 | 46,923,000 | 39,436,000 | 55,040,090 | 9,569,051 | 1,423,878 | 2,836,973 |
| Total Assets | 29,562,000 | 44,954,000 | 48,635,000 | 41,661,000 | 57,699,142 | 10,537,835 | 3,434,200 | 3,559,436 |
| Total Current Liabilities | 2,122,000 | 2,095,000 | 1,371,000 | 1,530,000 | 1,580,063 | 3,186,233 | 1,876,312 | 1,522,993 |
| Total Liabilities | 2,432,000 | 2,795,000 | 2,435,000 | 2,932,000 | 3,294,934 | 3,439,979 | 2,444,260 | 1,522,993 |
| Shareholders Equity | 27,130,000 | 42,159,000 | 46,200,000 | 38,729,000 | 54,404,208 | 7,097,856 | 989,940 | 2,036,443 |
| Shares Outstanding | 656,000 | 17,536,000 | 13,317,000 | 9,472,000 | 9,469,850 | 2,541,529 | 17,931,857 | 11,722,647 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 589,000 | 17,142,000 | 12,301,000 | 11,230,000 | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 589,000 | 17,142,000 | 12,301,000 | 11,230,000 | 8,680,000 | n/a | n/a | n/a |
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -4,062,000 | -4,013,000 | -4,883,000 | -7,049,000 | -4,954,000 | -6,699,000 | -6,170,000 | -5,454,000 | -5,503,000 | -6,278,000 | -5,349,000 | -6,814,000 | -6,797,000 | -6,460,000 | -6,151,000 | -6,986,000 | -5,335,000 | -8,992,259 | -2,706,531 | -2,385,463 |
| Net Income | -3,849,000 | -3,736,000 | -4,539,000 | -6,694,000 | -4,503,000 | -6,229,000 | -5,642,000 | -4,956,000 | -4,992,000 | -5,649,000 | -5,001,000 | -6,474,000 | -6,392,000 | -6,180,000 | -6,097,000 | -7,062,000 | -5,330,000 | -8,987,732 | -2,389,309 | -2,377,895 |
| Cash From Operations | -3,238,000 | -3,443,000 | -4,392,000 | -3,715,000 | -4,018,000 | -5,105,000 | -4,276,000 | -3,908,000 | -3,549,000 | -4,973,000 | -4,213,000 | -4,563,000 | -5,109,000 | -3,856,000 | -4,483,000 | -3,959,000 | -3,321,000 | -3,099,385 | -2,233,792 | -2,671,023 |
| Capex | n/a | n/a | 0 | n/a | n/a | -4,000 | -9,000 | -14,000 | -10,000 | -4,000 | -3,000 | -21,000 | -5,000 | -9,000 | -14,000 | -23,000 | -69,000 | -64,747 | -152,634 | -126,482 |
| Free Cash Flow | n/a | n/a | -4,392,000 | n/a | n/a | -5,109,000 | -4,285,000 | -3,922,000 | -3,559,000 | -4,977,000 | -4,216,000 | -4,584,000 | -5,114,000 | -3,865,000 | -4,497,000 | -3,982,000 | -3,390,000 | -3,164,132 | -2,386,426 | -2,797,505 |
| Cash And Equivalents | 2,597,000 | 3,065,000 | 1,544,000 | 2,044,000 | 2,937,000 | 1,754,000 | 17,915,000 | 2,380,000 | 2,314,000 | 3,620,000 | 4,946,000 | 4,714,000 | 2,273,000 | 4,555,000 | 2,895,000 | 9,070,000 | 51,338,000 | 54,727,740 | 57,896,922 | 41,039,182 |
| Total Current Assets | 25,489,000 | 28,826,000 | 31,499,000 | 35,604,000 | 39,479,000 | 43,734,000 | 49,051,000 | 39,536,000 | 43,248,000 | 46,923,000 | 26,217,000 | 30,108,000 | 34,519,000 | 39,436,000 | 40,708,000 | 37,760,000 | 51,650,000 | 55,040,090 | 58,206,968 | 41,438,867 |
| Total Liabilities | 2,350,000 | 2,432,000 | 2,905,000 | 3,520,000 | 2,270,000 | 2,795,000 | 3,020,000 | 2,577,000 | 2,460,000 | 2,435,000 | 3,179,000 | 3,274,000 | 2,484,000 | 2,932,000 | 2,785,000 | 3,374,000 | 2,907,000 | 3,294,934 | 1,118,132 | 1,477,894 |
| Shares Outstanding | 656,000 | 656,000 | 20,216,000 | 19,247,000 | 17,536,000 | 17,536,000 | 17,536,000 | 13,330,000 | 13,330,000 | 13,317,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,470,000 | 9,470,000 | 9,469,850 | 9,468,324 | 8,513,662 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 654,000 | 589,000 | 20,286,000 | 20,352,000 | 20,352,000 | 17,142,000 | 16,067,000 | 16,067,000 | 16,057,000 | 12,301,000 | 11,231,000 | 11,231,000 | 11,231,000 | 11,230,000 | 11,229,000 | 11,229,000 | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Basic | 654,000 | 589,000 | 20,286,000 | 20,352,000 | 20,352,000 | 17,142,000 | 16,067,000 | 16,067,000 | 16,057,000 | 12,301,000 | 11,231,000 | 11,231,000 | 11,231,000 | 11,230,000 | 11,229,000 | 11,229 | 11,229,000 | 8,680,000 | 9,180,000 | 8,512 |
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 25,489,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001661053/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661053\companyfacts.json |
| Total Liabilities | 2,350,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001661053/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661053\companyfacts.json |
| Cash | 2,597,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001661053/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661053\companyfacts.json |
| Shares Outstanding | 656,000 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001661053/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001661053\companyfacts.json |
| NCAV | 23,139,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 35.27USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 68.5% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-06; mary_accession=0001493152-26-021490; mary_cik=0001661053; gnni_supporting_filing_date=2026-05-06; internal_discount=0.685027; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.